Correspondence: Oral zinc sulfate for unresponsive cutaneous viral warts: Too good to be true? A double-blind, randomized, placebo-controlled trial

Clinical and Experimental Dermatology

Volumn 34, Issue 8, 2009, Pages

  Lopez Garcia D R ^a   Gomez Flores M ^a   Arce Mendoza, A Y ^a   De La Fuente Garcia A ^a   Ocampo Candiani, J ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GAMMA INTERFERON; INTERLEUKIN 2; PLACEBO; ZINC SULFATE; ANTIVIRUS AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; HUMAN; LETTER; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VERRUCA VULGARIS; VITAMIN SUPPLEMENTATION; VOMITING; ZINC DEFICIENCY; ORAL DRUG ADMINISTRATION; VIROLOGY;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; HUMANS; WARTS; ZINC SULFATE;

EID: 72549101535     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03623.x     Document Type: Letter

References (3)

1. Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol 2002 146 : 423 431.
2. Gibbs S. Zinc sulphate for viral warts. Br J Dermatol 2003 148 : 1082 1083.
3. Eng J. Sample size estimation: how many individuals should be studied? Radiology 2003 227 : 309 313.